Houwei Xu

Houwei Xu

Auto-generated profile, based on publicly available information

Houwei Xu

School of Mathematics and Computer Sciences, Nanchang University, Nanchang, China

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 September 2025 in IEEE Journal of Biomedical and Health Informatics
Verified
Journal Article
Closed access
MPMeng Pang
Meng Pang
HXHouwei Xu
Houwei Xu
ZHZheng Huang
Zheng Huang
YZYintao Zhou
Yintao Zhou
SCShengbo Chen
Shengbo Chen
WHWei HUANG
Wei HUANG
Early diagnosis of Parkinson's disease (PD) is crucial for timely treatment and disease management. Recent studies link PD to impaired facial muscle control, manifesting as “masked face” symptoms, offering a novel diagnostic approach through facial expression analysis. However, data privacy concerns and legal restrictions have resulted in significant “data silos”, hindering data sharing and limiting the accuracy and generalizability of existing diagnostic models due to small, localized datasets. To address these challenges, we propose an innovative Tri-Factor Adaptive Federated Learning (TriAFL) framework, designed to collaboratively analyze facial expression data across multiple medical institutions while ensuring robust data privacy protection. TriAFL introduces a comprehensive evaluation mechanism that assesses client contributions across three dimensions: gradient, data, and learning efficiency, effectively addressing Non-IID issues arising from data size variations and heterogeneity. To validate the real-world applicability of our method, we collaborate with a hospital to build the largest known facial expression dataset of PD patients. Furthermore, we explore the integration of local data augmentation strategy to further enhance diagnostic accuracy. Comprehensive experimental results demonstrate TriAFL's superior performance over conventional FL methods in classification task, as well as confirms TriAFL's efficacy in PD diagnosis, delivering a rapid, non-invasive screening tool while driving advancements in AI-powered healthcare.